+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

  • ID: 4844852
  • Report
  • 103 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • bioMerieux
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher
  • Leica Biosystems
  • MORE

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.

Test Segments: Market Sizing and Forecasts

There are several segments where testing at the molecular level has thrived, including the following:

  • HPV Testing
  • CT/NG Testing
  • Molecular Hepatitis Testing
  • HIV Testing
  • Hospital Acquired Infections and Sepsis Testing
  • Respiratory Diseases Testing
  • Mycobacteria/Tuberculosis Testing

The report does not contain information on blood banking, blood typing or NAT screen tests.

Regional Distribution

For each of these segments, the report provides a breakout for the following regions:

  • North America
  • Europe
  • Asia Pacific
  • Other

Company Profiles

Companies covered in this report include:

  • Abbott
  • bioMérieux
  • Bio-Rad
  • Cepheid
  • Meridian
  • Qiagen
  • Quidel
  • Roche
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • bioMerieux
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher
  • Leica Biosystems
  • MORE

Chapter One: Executive Summary

  • The Global Infectious Disease Molecular Diagnostics Market
  • Figure 1-1 Molecular Infectious Disease Market, 2019-2014
  • Test Segments
  • Emerging Trends Influencing the Market Landscape

Chapter Two: Developments in Molecular Infectious Disease Testing

  • Molecular POC: Upstart Competitors
  • Prospects for Molecular POC Testing for Infectious Diseases Diagnostics
  • Table 2-1: Selected Molecular POC Platforms in the Market for Infectious Disease Testing
  • Increased Presence of STDs
  • Lyme Disease: Major IVD Leaps in with Molecular Solutions
  • New Fungal Infection Spotlights Mass Spec and Sequencing
  • Updated Influenza Guidelines from the Infectious Diseases Society of America
  • PCR-based Assay for Diagnosis of Bacteremia Beats Blood Cultures in Study
  • Meridian Acquires GenePOC
  • T2Bacteria Study Demonstrates Worth in Recent Study
  • Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
  • Reimbursement Environment for Molecular Diagnostics
  • New Project Uses Sequencing for TB Diagnosis in Emerging Nations
  • Growing Microhospital Business Beckons Clinical Labs
  • New Eight Bacteria Gram-Negative Test Cleared by FDA
  • Clinical Utility of Molecular Diagnostics
  • AI Assisting with Molecular Colorectal Diagnosis

Chapter Three: Markets for Molecular Infectious Disease Diagnostics

  • Table 3-1: Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
  • Market Analysis - Global
  • Table 3-2: Market by Segments (%) (HIV and Hepatitis, Hospital, STIs and HPV, Other)
  • Table 3-3: Global Molecular Infectious Disease Diagnostics Markets (2019-2024), by Infection ($, Million) (Hepatitis, HIV, HAIs/Sepsis, HPV, CT/NG, Respiratory Diseases, Mycobacteria/TB, Other, Total)
  • Table 3-4: Global Molecular Infectious Disease Diagnostics Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • CT/NG, HPV and Women's Health
  • Table 3-5: Global Molecular HPV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Table 3-6: Global Molecular CT/NG Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hepatitis
  • Table 3-7: Global Molecular Hepatitis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • HIV
  • Table 3-8: Innovations in Molecular POC Diagnostics for HIV
  • Table 3-9: Global Molecular HIV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hospital-Acquired Infections (HAIs)
  • Table 3-10: Global Molecular HAIs/Sepsis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Respiratory Diseases
  • Table 3-11: Global Molecular Respiratory Diseases Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Mycobacteria/Tuberculosis
  • Table 3-12: Global Molecular Mycobacteria/TB Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)

Chapter Four: Company Profiles

  • Abbott Diagnostics
  • The Molecular Diagnostics Business Post-Acquisition of Alere
  • Becton, Dickinson & Co. (BD)
  • Business Segments
  • Molecular Diagnostics Focus
  • bioMerieux
  • Molecular
  • Bio-Rad Laboratories
  • Danaher (Cepheid and Leica Biosystems)
  • Life Sciences Business
  • Diagnostics Business
  • Cepheid
  • Leica Biosystems
  • Danaher’s 2018 Performance and 2019 Expectations
  • Acquisitions and Divestments in 2018 / 2019
  • Meridian Bioscience Inc
  • QIAGEN N.V.
  • Consumables and Related Revenues
  • Automation Platform and Instrumentation
  • Molecular Diagnostics Applications
  • Applied Testing
  • Pharma and Academia
  • New Developments (in 2018 until mid-2019)
  • Developments in Automation Systems
  • Bioinformatics Solutions
  • Quidel Corporation
  • Roche Diagnostics
  • Global Access Program for HIV
  • Core Molecular
  • cobas Liat System - POC
  • Partnering with Information Technology
  • Product Launches in 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Becton, Dickinson & Co. (BD)
  • bioMerieux
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher
  • Leica Biosystems
  • Meridian Bioscience Inc
  • Qiagen N.V.
  • Quidel Corporation
  • Roche Diagnostics
Note: Product cover images may vary from those shown
Adroll
adroll